Scarica l'app Stockscreener
0.60
2.90%
0.0169
Pre-mercato:
.59
-0.01
-1.67%
Century Therapeutics Inc Azioni (IPSC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
100.00%
-
|
109.16 | 4.173 | 0.791 | 0.771 |
| Operating Expenses |
0.93%
34.66
|
34.99 | 41.46 | 35.58 | 35.53 |
| Benefits Costs and Expenses |
65.14
|
- | 38.47 | 32.02 | 31.96 |
| Costs And Expenses |
65.14
|
- | 38.47 | 32.02 | 31.96 |
| Operating Income/Loss |
146.73%
-34.66
|
74.18 | -37.28 | -34.79 | -34.76 |
| Nonoperating Income/Loss |
10.95%
2.123
|
2.384 | 2.987 | 3.555 | 3.57 |
| Income/Loss From Continuing Operations Before Tax |
142.50%
-32.54
|
76.56 | -34.30 | -31.23 | -31.18 |
| Income/Loss From Continuing Operations After Tax |
142.50%
-32.54
|
76.56 | -36.07 | -31.23 | -31.21 |
Net Income/Loss
|
142.50%
-32.54
|
76.56 | -36.07 | -31.23 | -31.21 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.25%
86.24
|
86.02 | 2.2547 | 84.70 | 82.09 |
| Diluted Average Shares |
0.16%
86.24
|
86.10 | 2.2547 | 84.70 | 82.09 |
| Basic Earnings Per Share |
142.70%
-0.38
|
0.89 | -0.43 | -0.37 | -0.38 |
| Diluted Earnings Per Share |
142.70%
-0.38
|
0.89 | -0.43 | -0.37 | -0.38 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):